SCHEMBL5040984

SCHEMBL5040984

COC(C(=O)O)c1ccc(O)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 1/20 0.39
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
PTGS1 P23219 3/20 0.37
PTGS2 P35354 3/20 0.37
CYP3A4 P08684 2/20 0.36
APP P05067 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
FABP4 P15090 1/20 0.36
FABP5 Q01469 1/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
KMT2A Q03164 1/20 0.36
NR3C1 P04150 1/20 0.36
KDM4E B2RXH2 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2347876 0.82 PTGS2 (0.45) PTGS1PTGS2APPCYP2C19CYP1A2
SCHEMBL5041250 0.82 ALDH1A1 (0.53) ALDH1A1GAAPTGS1PTGS2L3MBTL1
SCHEMBL31147959 0.81 AKR1C3 (0.43) ALDH1A1GAAPTGS1PTGS2APP
SCHEMBL31147960 0.81 AKR1C3 (0.43) ALDH1A1GAAPTGS1PTGS2APP
SCHEMBL5042110 0.80 PDE2A (0.54) ALDH1A1GAAAPPCYP2C9CYP2C19
SCHEMBL16219361 0.77 PTGS1 (0.52) MIFPTGS1PTGS2CYP3A4APP
SCHEMBL5037418 0.77 ALDH1A1 (0.51) ALDH1A1GAACYP3A4L3MBTL1FABP4
SCHEMBL17724548 0.77 ALDH1A1 (0.51) ALDH1A1GAACYP3A4L3MBTL1FABP4
SCHEMBL5045302 0.76 MRGPRX4 (0.48) PPARGPPARA
SCHEMBL17241158 0.76 CES2 (0.45) ALDH1A1GAAPTGS1PTGS2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 MIF 481/4885ALDH1A1 519/4885GAA 1312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.